APA (7th ed.) Citation

JB, L., J, F., LJ, M., HE, D., C, D., MS, A., & ME, T. (2023). Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study. Drug safety, 46(2), 195. https://doi.org/10.1007/s40264-022-01260-6

Chicago Style (17th ed.) Citation

JB, Layton, Forns J, McQuay LJ, Danysh HE, Dempsey C, Anthony MS, and Turner ME. "Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study." Drug Safety 46, no. 2 (2023): 195. https://doi.org/10.1007/s40264-022-01260-6.

MLA (9th ed.) Citation

JB, Layton, et al. "Mortality in Patients with Parkinson's Disease-Related Psychosis Treated with Pimavanserin Compared with Other Atypical Antipsychotics: A Cohort Study." Drug Safety, vol. 46, no. 2, 2023, p. 195, https://doi.org/10.1007/s40264-022-01260-6.